Politician Dimitris Tsiodras aims to spark a debate on improving how the EU handles cardiovascular diseases by questioning how to boost prevention, reduce healthcare access inequalities, and promote personalized care. The spotlight is on national health systems, patients, and healthcare innovators — all likely to weigh in on potential shifts in funding and strategy.
Tsiodras posed his questions as a formal parliamentary inquiry, pressing the European Commission for clarity on the EU’s health priorities within cardiovascular care. His queries focus on system-wide prevention measures, cross-country healthcare disparities, and the role of upcoming EU budgets.
The Commission’s response reveals that while health service delivery stays mainly in national hands, the EU supplements efforts through initiatives like 'Healthier Together' and the EU4Health Programme, which has earmarked over €180 million for cardiovascular disease and prevention projects. Future plans include an EU Cardiovascular Health Plan targeting early detection, personalized treatment, and reduced health inequalities. The upcoming Multiannual Financial Framework (2028–2034) proposes a significant budget boost for health research and innovation, with nearly €20 billion for Horizon Europe and €22.6 billion for competitiveness in health-related sectors.
The policy direction leans towards reinforcing EU-level health research funding and innovation to complement national health system responsibilities. It emphasizes digital and personalized health solutions but maintains Member States’ sovereignty in actual healthcare provision.
Stakeholders like national health authorities may face stronger EU research and innovation priorities, potentially shifting resources. Patients could benefit from enhanced prevention and personalized care, while health tech and biotech industries might see increased opportunities. Conversely, some Member States may grapple with integrating new EU-driven measures or addressing persistent healthcare inequalities.
The Commission is expected to formalize further details during ongoing budget negotiations, offering key signals about the EU’s commitment to cardiovascular health in the coming years.